Stroke and Adverse Effects on The Immune and Cardiovascular Systems: The Danger of the Rise and Use of Psychedelic Drugs for Depression and PTSD
Journal of Clinical & Experimental Immunology – March 03, 2021
Source: OpenAlex
Summary
For centuries, plant-based hallucinogen drugs like psilocybin have been integral to native medicine. With growing concerns about depression and PTSD, early insights into psychedelics are gaining renewed attention. As early as 1950, reports suggested lysergic acid diethylamide (LSD) and other mood-altering drugs held potential for psychological and psychiatric treatment. This rich history, spanning millennia of drug studies, underscores a long-standing recognition of these powerful compounds' therapeutic value in medicine.
Abstract
Depression and post-traumatic stress disorder (PTSD), in the past two decades, has been a growing problem among adults and our youth. For hundreds, if not thousands of years, plant-based psychedelic drugs, such as psilocybin and peyote, have been utilized for medical purposes by numerous native tribal people As early as 1950, lysergic acid diethylamide (LSD), a synthetic mood-altering drug, a report was published that this drug and other psychedelics could be useful in the treatment of psychological and psychiatric problems [1].